The impact of carvedilol coadministration on enantioselective lercanidipine pharmacokinetics in patients with chronic kidney disease

被引：0
|
作者：
Schaab, Estela H.
Lanchote, Vera L.
Paiva, Carlos E. [1 ]
Dantas, Marcio [1 ]
Coelho, Eduardo B. [1 ]
机构：
[1] Univ Sao Paulo, Med Clin, BR-14049 Ribeirao Preto, Brazil
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2011年 / 51卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1358 / 1358
页数：1
相关论文
共 50 条
  • [1] Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease
    Schaab, Estela Hanauer
    Lanchote, Vera Lucia
    Balthazar Nardotto, Glauco Henrique
    Marques Pereira, Maria Paula
    Dantas, Marcio
    Paiva, Carlos Eduardo
    Coelho, Eduardo Barbosa
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 (01): : 75 - 85
  • [2] Influence of chronic chagas' disease on the enantioselective pharmacokinetics of carvedilol in hypertensive patients
    Poggi, J. C.
    Cesarino, E. J.
    Costa, P. C. B.
    Silva, F. G.
    Carvalho, T. M. J. P.
    Paula, C. S.
    Moraes-Junior, A. V.
    Zanardi, A. M. T.
    Lanchole, V. L.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1115 - 1115
  • [3] The Impact of Paroxetine Coadministration on Stereospecific Carvedilol Pharmacokinetics
    Stout, Stephen M.
    Nielsen, Jace
    Bleske, Barry E.
    Shea, Michael
    Brook, Robert
    Kerber, Kevin
    Welage, Lynda S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 15 (04) : 373 - 379
  • [4] Carvedilol use in pediatric patients with chronic kidney disease and ventricular dysfunction
    Watanabe, A.
    Leal, G. N.
    Oliveira, L. A. N.
    Koch, V. H. K.
    PEDIATRIC NEPHROLOGY, 2007, 22 (12) : 2170 - 2170
  • [5] Treatment of Arteril Hypertension in Patients With Chronic Kidney Disease: a Fixed Combination of Lercanidipine and Enalapril
    Minushkina, L. O.
    KARDIOLOGIYA, 2013, 53 (12) : 64 - 69
  • [6] INFLUENCE OF LERCANIDIPINE ON THE PHARMACOKINETIC-PHARMACODYNAMIC OF CARVEDILOL ENANTIOMERS IN PATIENTS WITH CHRONIC RENAL FAILURE
    Schaab, Estela Hanauer
    Lanchote, Vera Lucia
    Silva, Carolina Miranda
    Marques, Maria Paula
    Coelho, Eduardo Barbosa
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1074 - 1074
  • [7] Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysis
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (01) : 174 - 180
  • [8] CERA: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney disease
    Locatelli, Francesco
    Reigner, Bruno
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (10) : 1649 - 1661
  • [9] Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease
    Lerner, G
    Kale, AS
    Warady, BA
    Jabs, K
    Bunchman, TE
    Heatherington, A
    Olson, K
    Messer-Mann, L
    Maroni, BJ
    PEDIATRIC NEPHROLOGY, 2002, 17 (11) : 935 - 939
  • [10] Pharmacokinetics of Tecarfarin and Warfarin in Patients with Severe Chronic Kidney Disease
    Albrecht, Detlef
    Turakhia, Mintu P.
    Ries, Daniel
    Marbury, Thomas
    Smith, William
    Dillon, Debbie
    Milner, Peter G.
    Midei, Mark G.
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (11) : 2026 - 2033
12345